Document is current

Article History

Received: 12 July 2023

Accepted: 30 July 2023

First Online: 23 August 2023

Declarations

:

: G.C. has received consulting fees from BMS, Roche, Pfizer, Novartis, Lilly, Astra Zeneca, Daichii Sankyo, Merck, Seagen, Ellipsis and Gilead.

: This article does not contain any studies with human participants or animals performed by any of the authors.

: For this type of study informed consent is not required.